EV demonstrated comparable efficacy and tolerability in patients aged ≥80 years relative to younger counterparts. These findings support the safe and effective use of EV in elderly patients with mUC and highlight the need for further prospective studies in this population.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
个性的紫菜
科研狗
null
悲伤tomato
wanci
GingerF
pluto
123
Stella
互助
Dean
内向语梦
蓝莓橘子酱
你嵙这个期刊没买
pcr163
yyymmma
nn
lizishu
han
皖公网安备34019202002308
